For patients and the public

Glo-BNHL is a trial for children, adolescents and young people with B-cell non-Hodgkin’s Lymphoma (B-NHL) that does not go away (refractory B-NHL) or does but then comes back again (relapsed B-NHL).

It is an international multi-arm trial developed with a number of key organisations for research into childhood cancer, including Innovative Therapies for Children with Cancer (ITCC) and European Intergroup for Childhood NHL (EICNHL) in Europe; Children’s Oncology Group (COG) and C17 in North America; and the Australia and New Zealand Children's Haematology and Oncology Group (ANZCHOG). 

Professor Amos Burke

“This clinical trial is a direct result of international cooperation between childhood cancer parent representatives, medical teams, pharmaceutical companies and independent drug regulators to test new treatments for children and young people with very difficult to treat B-cell lymphoma. Together we hope to speed up the availability of more effective treatments to prevent more children dying from this type of lymphoma.”


Click here to download a Trial Summary for patients, and our latest Patient Newsletters